Which agency is responsible for defining and listing federally controlled drugs?

The Drug Enforcement Administration (DEA) is responsible for defining and listing federally controlled drugs in the United States. This agency operates under the Department of Justice and has the authority to categorize drugs into schedules based on their potential for abuse, medical usage, and safety. This scheduling system establishes the legal framework for the control and regulation of these substances, and it is essential for both public health and law enforcement.

The DEA not only sets the classifications but also monitors and enforces compliance with drug laws. It plays a crucial role in combating drug trafficking and abuse, thereby maintaining control over the distribution of controlled substances. By conducting evaluations and scheduling changes, the DEA ensures that the classification of drugs reflects current scientific evidence and societal needs.

Other agencies, while involved in various aspects of drug regulation, do not have the same mandate as the DEA in terms of defining and scheduling controlled substances. The FDA, for example, is primarily tasked with ensuring drug safety and efficacy but does not directly control drug scheduling. The Ohio Board of Pharmacy oversees pharmacy practice within the state but operates under the framework established by federal law. The National Institute on Drug Abuse focuses on research and information regarding substance use and its consequences rather than direct regulation.